Brought to you by 
Gene therapy start-up Generation Bio raises $100mm in Series B round
Mar 2018
Executive Summary
Generation Bio (gene therapy) raised $100mm in its Series B financing round led by Fidelity Management & Research and with participation from Invus, Deerfield Management, Casdin Capital, Foresite Capital, and Leerink Partners' affiliates.
Deal Industry
-
Biotechnology
- Gene Therapy, Cell Therapy
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Gene therapy start-up Generation Bio raises $100mm in Series B round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice